Cargando…

eMERGE Phenome-Wide Association Study (PheWAS) identifies clinical associations and pleiotropy for stop-gain variants

BACKGROUND: We explored premature stop-gain variants to test the hypothesis that variants, which are likely to have a consequence on protein structure and function, will reveal important insights with respect to the phenotypes associated with them. We performed a phenome-wide association study (PheW...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Anurag, Verma, Shefali S., Pendergrass, Sarah A., Crawford, Dana C., Crosslin, David R., Kuivaniemi, Helena, Bush, William S., Bradford, Yuki, Kullo, Iftikhar, Bielinski, Suzette J., Li, Rongling, Denny, Joshua C., Peissig, Peggy, Hebbring, Scott, De Andrade, Mariza, Ritchie, Marylyn D., Tromp, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989894/
https://www.ncbi.nlm.nih.gov/pubmed/27535653
http://dx.doi.org/10.1186/s12920-016-0191-8
_version_ 1782448623222521856
author Verma, Anurag
Verma, Shefali S.
Pendergrass, Sarah A.
Crawford, Dana C.
Crosslin, David R.
Kuivaniemi, Helena
Bush, William S.
Bradford, Yuki
Kullo, Iftikhar
Bielinski, Suzette J.
Li, Rongling
Denny, Joshua C.
Peissig, Peggy
Hebbring, Scott
De Andrade, Mariza
Ritchie, Marylyn D.
Tromp, Gerard
author_facet Verma, Anurag
Verma, Shefali S.
Pendergrass, Sarah A.
Crawford, Dana C.
Crosslin, David R.
Kuivaniemi, Helena
Bush, William S.
Bradford, Yuki
Kullo, Iftikhar
Bielinski, Suzette J.
Li, Rongling
Denny, Joshua C.
Peissig, Peggy
Hebbring, Scott
De Andrade, Mariza
Ritchie, Marylyn D.
Tromp, Gerard
author_sort Verma, Anurag
collection PubMed
description BACKGROUND: We explored premature stop-gain variants to test the hypothesis that variants, which are likely to have a consequence on protein structure and function, will reveal important insights with respect to the phenotypes associated with them. We performed a phenome-wide association study (PheWAS) exploring the association between a selected list of functional stop-gain genetic variants (variation resulting in truncated proteins or in nonsense-mediated decay) and an extensive group of diagnoses to identify novel associations and uncover potential pleiotropy. RESULTS: In this study, we selected 25 stop-gain variants: 5 stop-gain variants with previously reported phenotypic associations, and a set of 20 putative stop-gain variants identified using dbSNP. For the PheWAS, we used data from the electronic MEdical Records and GEnomics (eMERGE) Network across 9 sites with a total of 41,057 unrelated patients. We divided all these samples into two datasets by equal proportion of eMERGE site, sex, race, and genotyping platform. We calculated single effect associations between these 25 stop-gain variants and ICD-9 defined case-control diagnoses. We also performed stratified analyses for samples of European and African ancestry. Associations were adjusted for sex, site, genotyping platform and the first three principal components to account for global ancestry. We identified previously known associations, such as variants in LPL associated with hyperglyceridemia indicating that our approach was robust. We also found a total of three significant associations with p < 0.01 in both datasets, with the most significant replicating result being LPL SNP rs328 and ICD-9 code 272.1 “Disorder of Lipoid metabolism” (p(discovery) = 2.59x10-6, p(replicating) = 2.7x10-4). The other two significant replicated associations identified by this study are: variant rs1137617 in KCNH2 gene associated with ICD-9 code category 244 “Acquired Hypothyroidism” (p(discovery) = 5.31x103, p(replicating) = 1.15x10-3) and variant rs12060879 in DPT gene associated with ICD-9 code category 996 “Complications peculiar to certain specified procedures” (p(discovery) = 8.65x103, p(replicating) = 4.16x10-3).  CONCLUSION: In conclusion, this PheWAS revealed novel associations of stop-gained variants with interesting phenotypes (ICD-9 codes) along with pleiotropic effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12920-016-0191-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4989894
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49898942016-08-30 eMERGE Phenome-Wide Association Study (PheWAS) identifies clinical associations and pleiotropy for stop-gain variants Verma, Anurag Verma, Shefali S. Pendergrass, Sarah A. Crawford, Dana C. Crosslin, David R. Kuivaniemi, Helena Bush, William S. Bradford, Yuki Kullo, Iftikhar Bielinski, Suzette J. Li, Rongling Denny, Joshua C. Peissig, Peggy Hebbring, Scott De Andrade, Mariza Ritchie, Marylyn D. Tromp, Gerard BMC Med Genomics Research BACKGROUND: We explored premature stop-gain variants to test the hypothesis that variants, which are likely to have a consequence on protein structure and function, will reveal important insights with respect to the phenotypes associated with them. We performed a phenome-wide association study (PheWAS) exploring the association between a selected list of functional stop-gain genetic variants (variation resulting in truncated proteins or in nonsense-mediated decay) and an extensive group of diagnoses to identify novel associations and uncover potential pleiotropy. RESULTS: In this study, we selected 25 stop-gain variants: 5 stop-gain variants with previously reported phenotypic associations, and a set of 20 putative stop-gain variants identified using dbSNP. For the PheWAS, we used data from the electronic MEdical Records and GEnomics (eMERGE) Network across 9 sites with a total of 41,057 unrelated patients. We divided all these samples into two datasets by equal proportion of eMERGE site, sex, race, and genotyping platform. We calculated single effect associations between these 25 stop-gain variants and ICD-9 defined case-control diagnoses. We also performed stratified analyses for samples of European and African ancestry. Associations were adjusted for sex, site, genotyping platform and the first three principal components to account for global ancestry. We identified previously known associations, such as variants in LPL associated with hyperglyceridemia indicating that our approach was robust. We also found a total of three significant associations with p < 0.01 in both datasets, with the most significant replicating result being LPL SNP rs328 and ICD-9 code 272.1 “Disorder of Lipoid metabolism” (p(discovery) = 2.59x10-6, p(replicating) = 2.7x10-4). The other two significant replicated associations identified by this study are: variant rs1137617 in KCNH2 gene associated with ICD-9 code category 244 “Acquired Hypothyroidism” (p(discovery) = 5.31x103, p(replicating) = 1.15x10-3) and variant rs12060879 in DPT gene associated with ICD-9 code category 996 “Complications peculiar to certain specified procedures” (p(discovery) = 8.65x103, p(replicating) = 4.16x10-3).  CONCLUSION: In conclusion, this PheWAS revealed novel associations of stop-gained variants with interesting phenotypes (ICD-9 codes) along with pleiotropic effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12920-016-0191-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-12 /pmc/articles/PMC4989894/ /pubmed/27535653 http://dx.doi.org/10.1186/s12920-016-0191-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Verma, Anurag
Verma, Shefali S.
Pendergrass, Sarah A.
Crawford, Dana C.
Crosslin, David R.
Kuivaniemi, Helena
Bush, William S.
Bradford, Yuki
Kullo, Iftikhar
Bielinski, Suzette J.
Li, Rongling
Denny, Joshua C.
Peissig, Peggy
Hebbring, Scott
De Andrade, Mariza
Ritchie, Marylyn D.
Tromp, Gerard
eMERGE Phenome-Wide Association Study (PheWAS) identifies clinical associations and pleiotropy for stop-gain variants
title eMERGE Phenome-Wide Association Study (PheWAS) identifies clinical associations and pleiotropy for stop-gain variants
title_full eMERGE Phenome-Wide Association Study (PheWAS) identifies clinical associations and pleiotropy for stop-gain variants
title_fullStr eMERGE Phenome-Wide Association Study (PheWAS) identifies clinical associations and pleiotropy for stop-gain variants
title_full_unstemmed eMERGE Phenome-Wide Association Study (PheWAS) identifies clinical associations and pleiotropy for stop-gain variants
title_short eMERGE Phenome-Wide Association Study (PheWAS) identifies clinical associations and pleiotropy for stop-gain variants
title_sort emerge phenome-wide association study (phewas) identifies clinical associations and pleiotropy for stop-gain variants
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989894/
https://www.ncbi.nlm.nih.gov/pubmed/27535653
http://dx.doi.org/10.1186/s12920-016-0191-8
work_keys_str_mv AT vermaanurag emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT vermashefalis emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT pendergrasssaraha emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT crawforddanac emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT crosslindavidr emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT kuivaniemihelena emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT bushwilliams emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT bradfordyuki emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT kulloiftikhar emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT bielinskisuzettej emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT lirongling emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT dennyjoshuac emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT peissigpeggy emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT hebbringscott emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT deandrademariza emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT ritchiemarylynd emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants
AT trompgerard emergephenomewideassociationstudyphewasidentifiesclinicalassociationsandpleiotropyforstopgainvariants